These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26160095)

  • 1. Intermittent levetiracetam treatment in five patients with catamenial epilepsy.
    Liu J; Yu N; Sun H; Liang Y; Xie Y; Chen K
    J Pak Med Assoc; 2015 Jul; 65(7):793-5. PubMed ID: 26160095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam efficacy in children with epilepsy with electrical status epilepticus in sleep.
    Chen J; Cai F; Jiang L; Hu Y; Feng C
    Epilepsy Behav; 2015 Mar; 44():73-7. PubMed ID: 25632834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair loss with levetiracetam in five patients with epilepsy.
    Zou X; Hong Z; Zhou D
    Seizure; 2014 Feb; 23(2):158-60. PubMed ID: 24315496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
    Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of long-term low-dose levetiracetam treatment for epilepsy.
    Yoshikawa S; Shimakawa S; Fukui M; Nomura S; Tanabe T; Tamai H
    Pediatr Int; 2016 Jan; 58(1):40-4. PubMed ID: 26189956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in patients with refractory epilepsy: results of the SKATE trial in Austria, Germany and Switzerland.
    Steinhoff BJ; Trinka E; Wieser HG;
    Seizure; 2005 Oct; 14(7):490-6. PubMed ID: 16169256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D; French JA
    Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy.
    Grant R; Shorvon SD
    Epilepsy Res; 2000 Dec; 42(2-3):89-95. PubMed ID: 11074181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
    Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
    Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony.
    Kanemura H; Sano F; Sugita K; Aihara M
    Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.
    Betts T; Waegemans T; Crawford P
    Seizure; 2000 Mar; 9(2):80-7. PubMed ID: 10845730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tolerance to levetiracetam in rats with chronic epilepsy.
    van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
    Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent oral levetiracetam reduced recurrence of febrile seizure accompanied with epileptiform discharge: a pilot study.
    Hu LY; Shi XY; Li H; Zhang MN; Ma SF; Zou LP
    Ital J Pediatr; 2018 Jun; 44(1):70. PubMed ID: 29907116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous levetiracetam for epileptic seizure emergencies in older people.
    Beyenburg S; Reuber M; Maraite N
    Gerontology; 2009; 55(1):27-31. PubMed ID: 18953167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.